As an innovator in reagents and tools, Abcam’s purpose is to serve life science researchers globally to achieve their mission, faster.
|Address:||330 Cambridge Science Park, Cambridge|
|Membership type:||Founder Member|
As an innovator in reagents and tools, Abcam’s purpose is to serve life science researchers globally to achieve their mission, faster. Providing the research and clinical communities with tools and scientific support, the Company offers highly validated biological binders and assays to address important targets in critical biological pathways.
Already a pioneer in data sharing and ecommerce in the life sciences, Abcam’s ambition is to be the most influential company in life sciences by helping advance global understanding of biology and causes of disease, which, in turn, will drive new treatments and improved health.
Two-thirds of the world’s 750,000 life science researchers use Abcam’s affinity binders, reagents, biomarkers and assays and the Company’s products are mentioned in over 20,000 of the 56,000 peer-reviewed papers published each year in the life sciences.
By actively listening to and collaborating with researchers, the Company continuously advances its portfolio to address their needs. A transparent programme of customer reviews and datasheets, combined with an industry-leading validation initiative, gives researchers increased confidence in their results.
Abcam’s ten offices are located in the world’s leading life science research hubs, enabling local services and multi-language support. Founded in 1998 and headquartered in Cambridge, UK, the Company sells to more than 100 countries. Abcam was admitted to AIM in 2005 (AIM: ABC).
To find out more, please visit www.abcam.com
Abcam plc, a global leader in the supply of life science research tools, today announces that it has entered into a definitive agreement to acquire the entire issued share capital of Firefly BioWorks Inc on a cash-free/debt-free basis for £18.5m ($28.0m).
21 January 2015Read in full
Abcam plc, a global leader in the supply of life science research tools, announced today it has signed an exclusive partnership agreement with the Institute of Molecular and Cell Biology (IMCB), a research institute under the Agency for Science, Technology and Research (A*STAR), Singapore.
8 January 2015Read in full
Have you ever wondered what it is like to be an editor at a high impact journal? Katharine Wrighton, Chief Editor of Nature Reviews Molecular Cell Biology, talks about her journey from laboratory to editorial office.
22 December 2014Read in full
Abcam plc, a global leader in the supply of life science research tools, is pleased to announce the appointment of Sue Harris as a non-Executive Director on the Abcam Board. Sue will join the Board with immediate effect and will Chair the Audit Committee.
12 December 2014Read in full
Abcam plc, a global leader in the supply of protein research tools and services, announced today that it has appointed Yvonne Chien as Chief Digital Officer. The Company also announced the appointment of Sue Harris as non-Executive Director to the Abcam Board, further strengthening Abcam’s leadership team.
12 December 2014Read in full
Abcam plc., a leading provider of protein research tools and services, announced today that it has won the Life Science Industry Award for the ‘Best use of digital media’.
19 November 2014Read in full
Abcam plc (AIM: ABC), a global leader in the supply of life science research tools, is pleased to announce the appointment of Alan Hirzel as Chief Executive Officer with immediate effect. Alan will succeed long-serving Chief Executive and co-Founder of Abcam Jonathan Milner, who will continue to play an active role in the Company as Deputy Chairman and who remains the Company's largest shareholder.
9 September 2014Read in full